Nu.Q® Discover: work with us

 

Category: Biotech Service

Exhibitor: BELGIAN VOLITION SRL

Booth No: M807

 

Characteristic

 

How we can help.
Nu.Q® Discover is a complete solution to profiling nucleosomes and empowers drug developers and scientists offering rapid epigenetic profiling in disease model development, preclinical testing, and clinical studies – from drug discovery to market ready.

Nu.Q® Discover is an invaluable research tool for R&D professionals working within the field of Pharmacoepigenetics, studying the epigenetic basis for variation in response to drugs.

Nu.Q® Discover is built on Volition’s cutting-edge Nu.Q® nucleosome quantification technology and adds value across the drug development pipeline, with applications in:
•Oncology
•Neurodegenerative diseases
•Autoimmune diseases
•NETosis

Use our Nu.Q® Discover assays to test sensitively for circulating nucleosomes and gain deep insights into how drug actions are impacted by epigenetic alterations. Our biomarkers support the entire drug discovery and development process from pre-clinical testing to market ready.

Identify:
• Drug targets/novel inhibitors
• Mechanism of Action (MoA)
• Biomarkers

Demonstrate:
•Pharmacodynamics (PD) monitoring of target engagement
•On/Off target activities and effects
•Correlation with gene expression and cancer progression
•Efficacy: in-vitro/in-vivo

Accelerate:
•Use same assay for drug screen on cell culture to clinical studies
•Demonstrated in a variety of cells and animal models
•Combine assays for a comprehensive overview

 

Other Products

 

• 

  Nu.Q® Discover H3.1 Research Use Only Assay

 

 

 

Back